Literature DB >> 9925279

Profiles of the fatty acids in the plasma membrane of human brain tumors.

E Kökoğlu1, Y Tüter, Z Yazici, K S Sandikci, H Sönmez, E Z Ulakoğlu, E Ozyurt.   

Abstract

Several studies demonstrated that certain fatty acids have specific effects on tumor cells. n-3 series fatty acids (alpha-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid) may suppress the carcinogenesis, whereas n-6 series fatty acids (arachidonic acid, linoleic acid) may exert tumor promoting effects. In this study, 19 patients with various brain tumors and 12 control brain tissues were studied. n-3, n-6, n-9 unsaturated fatty acids and certain saturated fatty acids levels were measured in the plasma membrane of tumor or control brain tissues by capillary gas chromatography. We found that the level of docosahexaenoic acid from n-3 series fatty acids was significantly lower in gliomas and meningiomas than controls (p = 0.000). Total n-3 fatty acids level was also significantly lower in tumors than controls (p = 0.000). The levels of linoleic acid, arachidonic acid and dihomogamma linolenic acid from n-6 series were significantly higher in gliomas and meningiomas compared with controls (p = 0.000). Total n-6 fatty acids level was also significantly higher in tumors than controls (p = 0.000). Furthermore, in total n-9 fatty acids, total unsaturated fatty acids and total saturated fatty acids levels, there were no significant differences in gliomas and meningiomas compared with controls (p = 0.6840, p = 0.4388 and p = 0.4343, respectively). This findings suggest that n-6 fatty acids can act as a tumor-promoting agent in human brain tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925279

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  9 in total

1.  Quantification of free fatty acids in human cerebrospinal fluid.

Authors:  J G Pilitsis; F G Diaz; J M Wellwood; M H Oregan; M R Fairfax; J W Phillis; W M Coplin
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

Review 2.  Lipids, mitochondria and cell death: implications in neuro-oncology.

Authors:  Alison Colquhoun
Journal:  Mol Neurobiol       Date:  2010-04-29       Impact factor: 5.590

3.  Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Authors:  Helena Gleissman; Rong Yang; Kimberly Martinod; Magnus Lindskog; Charles N Serhan; John Inge Johnsen; Per Kogner
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

4.  Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.

Authors:  Ninib Baryawno; Baldur Sveinbjörnsson; Staffan Eksborg; Abiel Orrego; Lova Segerström; Carl Otto Oqvist; Stefan Holm; Bengt Gustavsson; Bertil Kågedal; Per Kogner; John Inge Johnsen
Journal:  Neuro Oncol       Date:  2008-08-20       Impact factor: 12.300

5.  Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma.

Authors:  Ersoy Oksuz; Fatmahan Atalar; Gamze Tanırverdi; Ayahan Bilir; Andleeb Shahzadi; Zeliha Yazici
Journal:  J Neurooncol       Date:  2015-10-27       Impact factor: 4.130

Review 6.  The eicosanoid cascade: possible role in gliomas and meningiomas.

Authors:  N Nathoo; G H Barnett; M Golubic
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

Review 7.  Is human cytomegalovirus a target in cancer therapy?

Authors:  John Inge Johnsen; Ninib Baryawno; Cecilia Söderberg-Nauclér
Journal:  Oncotarget       Date:  2011-12

8.  Might salicylate exert benefits against childhood cancer?

Authors:  G Morgan; Ji Johnsen
Journal:  Ecancermedicalscience       Date:  2010-01-19

9.  The influence of feeding linoleic, gamma-linolenic and docosahexaenoic acid rich oils on rat brain tumor fatty acids composition and fatty acid binding protein 7 mRNA expression.

Authors:  Javad Nasrollahzadeh; Fereydoun Siassi; Mahmood Doosti; Mohammad Reza Eshraghian; Fazel Shokri; Mohammad Hossein Modarressi; Javad Mohammadi-Asl; Khosro Abdi; Arash Nikmanesh; Seyed Morteza Karimian
Journal:  Lipids Health Dis       Date:  2008-11-16       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.